Washington Examiner Op-Ed Gets the Facts Wrong on Menhaden, American Jobs and Fisheries Management

The American Small Pelagics Network rebutted criticism of Atlantic and Gulf menhaden fishing, citing 2025 assessments that found both stocks not overfished and not subject to overfishing. It said the ASMFC's 2026 Atlantic catch level carries a modeled 0% probability of exceeding the ecological overfishing threshold, while 89% of 2022-23 striped bass removals came from recreational harvest and release mortality. The industry group also said 70% of Omega Protein's 2025 marine-ingredient sales went to U.S. customers and cited estimates of roughly 519 full- and part-time Maryland/Virginia jobs tied to the reduction sector.

Analysis

This is advocacy counter-messaging rather than a new regulatory, quota, pricing, or earnings datapoint; the market impact is therefore negligible absent confirmation that Atlantic or Gulf harvest limits are being reconsidered. The relevant economic exposure sits largely in private Cooke/Omega operations, making EMP.A an unsuitable direct proxy despite the supplied ticker. The more investable read-through is to marine-ingredient and aquaculture-input markets: a binding harvest restriction would tighten fishmeal/fish-oil supply and modestly support substitute inputs, but no such policy catalyst is identified here.

Near term, watch ASMFC meeting agendas, state purse-seine rulemaking, and any independently released bycatch or predator-stock data rather than company-sponsored characterization of existing science. Over 6-18 months, the principal tail risk is not a broad commodity shock but a localized regulatory constraint that raises fixed-cost absorption risk at concentrated processing assets; a modest quota reduction can have disproportionate margin and employment effects where plant utilization is the key variable. The contrarian point is that public debate can create headline volatility without changing harvest economics: absent a formal catch-limit proposal, the probability-adjusted impact on listed seafood, feed, and logistics equities remains too low to justify a position.

Key Decisions for Investors

• No trade in EMP.A: verify issuer relevance before treating it as an exposure to menhaden, Cooke Seafood, or Omega Protein; the supplied ticker does not provide a clear operating linkage.
• Set a regulatory alert for ASMFC or Louisiana/Mississippi proposals that change allowable catch, seasonal access, or purse-seine operating rules. Escalate only if a proposal includes a quantified reduction or new compliance cost; that would create a 1-3 month marine-ingredient supply catalyst.
• Monitor fish-oil and fishmeal benchmark prices plus aquaculture-feed producer commentary over the next two earnings cycles. A sustained price move accompanied by formal harvest restrictions—not advocacy headlines alone—would support examining long substitute-protein or marine-ingredient beneficiaries.
• Treat any sector selloff tied solely to this narrative as noise unless it is accompanied by revised quota guidance, processing-utilization disclosures, or enforceable state/interstate rulemaking; those are the thesis-falsification and entry triggers.